Novel antimicrobial activities of a peptide derived from a Japanese soybean fermented food, Natto, against Streptococcus pneumoniae and Bacillus subtilis group strains
Manabu Kitagawa,
Tsukasa Shiraishi,
Soh Yamamoto,
Ryosuke Kutomi,
Yasuo Ohkoshi,
Toyotaka Sato,
Hideki Wakui,
Hideaki Itoh,
Atsushi Miyamoto,
Shin-ichi Yokota
Affiliations
Manabu Kitagawa
Department of Microbiology, Sapporo Medical University School of Medicine
Tsukasa Shiraishi
Department of Microbiology, Sapporo Medical University School of Medicine
Soh Yamamoto
Department of Microbiology, Sapporo Medical University School of Medicine
Ryosuke Kutomi
Department of Microbiology, Sapporo Medical University School of Medicine
Yasuo Ohkoshi
Department of Microbiology, Sapporo Medical University School of Medicine
Toyotaka Sato
Department of Microbiology, Sapporo Medical University School of Medicine
Hideki Wakui
Department of Life Science, Graduate School and Faculty of Engineering Science, Akita University
Hideaki Itoh
Department of Life Science, Graduate School and Faculty of Engineering Science, Akita University
Atsushi Miyamoto
Department of Pharmaceutical Health Care and Sciences, Sapporo Medical University School of Medicine
Shin-ichi Yokota
Department of Microbiology, Sapporo Medical University School of Medicine
Abstract We recently isolated a tumoricidal peptide from Natto, a Japanese traditional fermented food. In the present study, antimicrobial activity of the Natto peptide was examined. The peptide consisted of 45 amino acid residues, and its structure was predicted to be rich in α-helix. It excreted antimicrobial activity only against Streptococcus pneumoniae and Bacillus subtilis group (B. subtilis, Bacillus pumilus, and Bacillus licheniformis). Lesser antimicrobial activity was observed for Streptococcus species other than S. pneumoniae. Hemolysate or hemin was required for the antimicrobial activity of the peptide. The Natto peptide damages the cell membrane of B. subtilis. On the other hand, chain morphology was induced in S. pneumoniae, which is naturally diplococcus, during the early phases of the Natto peptide treatment; following that the cells were rapidly lysed. This suggested that the Natto peptide displayed a novel narrow spectrum of bactericidal activity and inhibited cell separation during cell division of S. pneumoniae.